Search
for

    Sort by

    Research 181–210 of 1000+

    1. Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis International Journal of Trichology · 2025
    2. Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice Bioscience Reports · 2021 · 14 citations
    3. Pathomechanisms of immune-mediated alopecia International Immunology · 2019 · 45 citations
    4. Baricitinib: A Review in Severe Alopecia Areata American Journal of Clinical Dermatology · 2023 · 1 citations
    5. Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series Clinical, cosmetic and investigational dermatology · 2024
    6. Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study Frontiers in medicine · 2023
    7. Biologics in the management of childhood atopic dermatitis 2023 · 4 citations
    8. Mechanistic Insights into Plant-Derived Exosomes, Their Cross-Kingdom Effects, and Potential Biomedical Applications in Skin Wounds Repair Plants · 2026
    9. Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata Dermatologic therapy · 2024
    10. Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention Frontiers in Cell and Developmental Biology · 2021 · 61 citations
    11. Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review Dermatology and Therapy · 2025
    12. Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies Current issues in molecular biology · 2024
    13. DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF Figshare · 2021
    14. Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature Medicina · 2024
    15. What is behind the ‘swarm of bees’ in alopecia areata British Journal of Dermatology · 2018 · 7 citations
    16. An ERK-dependent molecular switch antagonizes fibrosis and promotes regeneration in spiny mice ( <i>Acomys</i> ) Science Advances · 2023 · 1 citations
    17. Exosomes Secreted from Adipose-Derived Stem Cells Are a Potential Treatment Agent for Immune-Mediated Alopecia Journal of immunology research · 2022 · 6 citations
    18. Peripheral neuropathy associated with tofacitinib use in alopecia universalis Journal of Dermatology and Dermatologic Surgery · 2022 · 1 citations
    19. Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats Frontiers in Veterinary Science · 2026
    20. Poly-D,L-Lactic Acid Filler Increases Hair Growth by Modulating Hair Follicular Stem Cells in Aged Skin Cells · 2025
    21. Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration Journal of Clinical Medicine · 2025
    22. Alopecia Areata: Pathogenesis, current treatments, and future perspectives Journal of Education Health and Sport · 2025
    23. Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia Life · 2024
    24. CXCL12 inhibits hair growth through CXCR4 Biomedicine & Pharmacotherapy · 2022
    25. An Updated in the Management of Alopecia Areata IntechOpen eBooks · 2023
    26. Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib Frontiers in Immunology · 2021 · 6 citations
    27. Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype 2025
    28. Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model International Journal of Molecular Sciences · 2024
    29. Ruxolitinib found to cause eyelash growth: a case report Journal of medical case reports · 2017 · 9 citations
    30. A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol Skin Health and Disease · 2025 · 1 citations